COVID RTW Screening

Akeso is your source
for return to work

Professional medical screening keeps exposure to sick employees to a minimum, boosts employees’ confidence about coming back to work and avoids risk-exposure and non-compliance by employers.

As the COVID-19 pandemic starts to subside, businesses are looking to return to work. The question for many business owners is, “When can my staff return to work and how can they do so as safely as possible?”  

As officials continue to discuss plans to reopen businesses, the Centers for Disease Control recently unveiled new guidelines for bringing workers back. They outline how business owners can determine which staff members are ready to return to work, when, and under what conditions. Their recommendations outline differing scenarios based on the employee’s current or recent past health status with regard to COVID-19.

Additionally, the EEOC has now affirmed that employers are permitted to “administer safe and accurate” COVID-19 testing to determine whether employees are currently infected before allowing employees to return to work.

Akeso provides your organization with on-site screening for baseline risk factors related to attending work under the COVID Pandemic Guidelines as provided by the CDC and EEOC, which include taking employee temperatures and implementing a screening questionnaire. We offer several different plans available for employers depending on your needs.

Return to work screening process

Akeso will provide three resources, two medically credentialed (either CNA, MA or EMT) and one administrative coordinator to provide on-location screening of employees using a questionnaire and temperature check. Our process for screening and testing is as follows:       

  • Employee completes our questionnaire, which they can fill out either before coming to work or when upon arrival.     
  • Coordinator gathers questionnaires and highlights any responses requiring further follow-up by the credentialed screeners.     
  • Screeners take temperature and review any concerning responses in the questionnaire to determine whether an employee is at risk.     
  • Employees not at risk can proceed to their jobs and will receive a wristband indicating they passed screening. Employees at risk will be asked to return home and we will arrange a telemedicine appointment with our doctors.     
  • Results would be stored in a HIPPA compliant manner, and the only communication with the employer would be if the employee was passed or sent home for further follow-up. If the employer has a HIPPA compliant record for the employee, the screening results and temperature will be provided for employees sent home for further follow-up.     
  • Doctor will complete a telemedicine consult and determine whether the employee should submit to testing or other plan based on their findings.

Additional anti-body testing If a Akeso Doctor detremines an employee is at risk , they may be referred for COVID-19 IgG antibody testing, also known as serology testing, which checks for a type of antibody called immunoglobulin G (IgG). If they have been exposed to the virus that causes COVID-19, their body typically produces IgG antibodies as part of the immune response to the virus.

Antibody tests may not be able to show if you have been exposed to COVID-19 because it can take at least two weeks after exposure to develop antibodies.

Akeso offers PCR Molecular Drive-Thru Coronavirus (COVID-19) swab test for our clients. Per the Center for Disease Control and Prevention (CDC) guidelines only symptomatic and high-risk category patients with a doctor’s prescription can get tested. We can test everybody – no doctor’s prescription needed.

Screening Plans

Akeso’s RTW Screening Plans are per hour and are the same for testing and screening. Both plans require a contract. Akeso is offering different levels of medical professionals to suit your needs.       

  • Screening service is a minimum of four (4) hours per day with a minimum of two (2) person MA/EMT level plus one (1) adminsitrative coordinator and a commitment of at least 30-days for the initial rollout. Akeso supplies all PPE and equipment for the screening process.     
  • Anti-body testing can be one time only, with a minimum of four (4) hours per day with a minimum of two (2) persons (two phlebotomists). There is an additional fee/IGG Antibody test per person. Lab results are a minimum of two days.

For pricing and further information,
Contact Akeso at: 949.752.1111 or
to discuss a plan that is right for your organization

    • RTW_Screening_Team.png
    • RTEW_Patient.png
    • RTW_Screening_2.png
    • RTW_Screening_DriveUp_4.png
    • RTW_Screening_DriveUp.png

    Testing types


    Virus test (Antigen)

    This test detects the virus (SARS-CoV-2) to determine if you have an active infection and are infectious, i.e., you can spread the virus. Although you can be infectious before showing any symptoms, the virus is best detected during the first week of symptoms (which is about two weeks after becoming infected from exposure) 


    The virus test is best done by collecting a sample of mucous from a swab (typically from the nasopharynx or nostril) or saliva. This sample then needs to be analyzed in a laboratory or with a special rapid, portable machine using a technique that amplifies the genetic material (RNA) from the virus. This can take as little as a few minutes or several hours. The FDA has begun allowing some at-home sampling kits to be sold by which you can collect your own sample and drop it off or mail it to a lab, which will report the results back to you. 

    NOTE: Fully gowned and masked health care worker to obtain the NP swab for antigen because the patient coughs on the HCW when the swab is inserted to the proper depth. 


    Antibody test 

     The other detects antibodies to the virus and requires blood — either a drop or a vial — to determine if you have been infected in the past and have developed some level of immunity. This test (also called a serology test) can be run in a laboratory or on a test strip. However, the accuracy of test strips has been found to vary, so you need to be careful if using a home-based test. None have been allowed by the FDA. As it takes time to develop antibodies that can be detected, antibody tests are most accurate when performed at least 20 days after the first disease symptoms. Tests focus on levels of the antibody IgG, which persists without much decline for several weeks, but may include levels of IgM which fall off more rapidly